A Phase II Randomized, Observer-blind Controlled Pilot Study to Compare the Safety and Immunogenicity of Acellular Pertussis Vaccines Including Chemically or Genetically-detoxified Pertussis Toxin in Adolescents Aged 11-15 Years Previously Immunized With Acellular Pertussis Vaccines
Latest Information Update: 21 Feb 2019
At a glance
- Drugs Pertussis acellular vaccine (Primary)
- Indications Pertussis
- Focus Pharmacodynamics; Proof of concept
- Acronyms PertADO
- 05 Sep 2017 New trial record